CIK 0001635088 · Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- operating
- EIN
- 981173944
- Phone
- 441-295-5950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $85,719,562
- in 13 filings, $45.5M under 10b5-1 plans
Net −$85,719,562. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-16 | Fitzgerald Meghan Director | Grant or award | +5,054 | 41,162 | ||
| 2026-09-16 | Fitzgerald Meghan Director | Grant or award · Stock Option (Right to Buy) | +10,531 | 10,531 | ||
| 2026-09-15 | Fitzgerald Meghan Director | Sale 10b5-1 | −4,712 | $39.68 | $187K | 36,508 |
| 2026-09-15 | Fitzgerald Meghan Director | Sale 10b5-1 | −400 | $40.45 | $16K | 36,108 |
| 2026-09-10 | Fitzgerald Meghan Director | Shares withheld for taxes | −1,743 | $40.94 | $71K | 41,220 |
| 2026-09-08 | Fitzgerald Meghan Director | Option exercise 10b5-1 | +20,000 | $8.80 | $176K | 62,963 |
| 2026-09-08 | Fitzgerald Meghan Director | Sale 10b5-1 | −20,000 | $39.90 | $798K | 42,963 |
| 2026-09-08 | Fitzgerald Meghan Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,000 | 18,578 | ||
| 2026-06-30 | Fitzgerald Meghan Director | Option exercise 10b5-1 | +10,000 | $8.80 | $88K | 52,963 |
| 2026-06-30 | Fitzgerald Meghan Director | Sale 10b5-1 | −10,000 | $34.90 | $349K | 42,963 |
| 2026-06-30 | Fitzgerald Meghan Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 38,578 | ||
| 2026-03-26 | Fitzgerald Meghan Director | Option exercise | +70,000 | $8.80 | $616K | 112,963 |
| 2026-03-26 | Fitzgerald Meghan Director | Sale | −70,000 | $27.45 | $1.9M | 42,963 |
| 2026-03-26 | Fitzgerald Meghan Director | Option exercise · Stock Option (Right to Buy) | −70,000 | 48,578 | ||
| 2025-09-10 | Fitzgerald Meghan Director | Grant or award | +14,524 | 43,900 | ||
| 2025-09-10 | Fitzgerald Meghan Director | Other disposition | −937 | $13.77 | $13K | 42,963 |
| 2025-09-10 | Fitzgerald Meghan Director | Grant or award · Stock Option (Right to Buy) | +33,726 | 33,726 |
Page 1 of 1 · 17 trades